Ibrutinib
Ibrutinib · Bruton's Tyrosine Kinase (BTK) Inhibitor
Indications & Uses
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.
Contraindications
Hypersensitivity to active ingredient or any formulation excipients.
Side Effects & Warnings
Bleeding/hemorrhage, cardiac arrhythmias (atrial fibrillation), hypertension, cytopenias, infections, diarrhea.
Drug & Dietary Interactions
Caution with strong CYP3A inhibitors or inducers; review concurrent medications.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.